Product Recall: Peg-Intron® REDIPEN Injection

SOL Limited (Singapore Branch), a subsidiary of Merck& Co. Inc, is conducting a voluntary recall, to the pharmacy/retailer level, of all strengths of Peg-Intron® REDIPEN Injection as a precautionary measure due to a potential defect in the glass cartridge component of the product delivery system. As a result of this defect, a limited number of REDIPEN units may have a potential risk for contamination since the container seal may be compromised. With effect from 18 Sept 2010, all sales of Peg-Intron® REDIPEN Injections have been suspended and all existing stocks of all the affected batches will be recalled. Until unaffected units of Peg-Intron ® REDIPEN become available, healthcare professionals are advised NOT to initiate Peg-Intron ® treatment on NEW patients and to consider switching existing patients to alternative therapies.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.